LPA ELISA Assay Service

Catalog No.:  T-2800s

Description:  The LPA assay services uses the LPA ELISA II kit (K-2800s) to quantify LPA in biological samples (96-well format).

Assay Range: 0.064 μM to 1,000 μM LPA
Inter Assay CV: 8.9-15.33%
Intra Assay CV: 6.5-8.7%
Sample Amount: 50 μL is required

Lysophosphatidic Acid (LPA) is a serum-derived phospholipid involved in diverse cellular processes such as cell proliferation, chemotaxis, platelet aggregation, wound healing, angiogenesis, tumor invasion, and smooth muscle contraction. Recent research indicates LPA may play a significant role in the pathophysiology of cancer and may be used as a biomarker for ovarian cancer. (Several literature citations indicate plasma LPA levels are elevated in ovarian cancer patients).
LPA is quantified using Echelon’s LPA ELISA II catalog # K-2800s (see K-2800s TDS for more information). The LPA ELISA II is a sensitive and robust method for quantification of serum LPA in a 96-well plate competitive ELISA format. As little as 50 μL of sample is sufficient for duplicate data points. Each sample will be run in duplicate unless indicated by the customer to do other wise. The data will be provided as an average of the duplicate data points. The LPA Assay Kit was co-developed using the proprietary monoclonal antibody of Lpath Inc. (San Diego, CA.

Please refer to the technical data sheet for sample considerations and shipping information. To place an order please contact Echelon at 801.588.0455.


Lpath, Inc. has a number of patent applications pending or issued covering material(s) incorporated into this assay. The assay`s intended use is for the measurement of LPA in biological samples. Any other use, including drug discovery, requires a license from Lpath (

Options/Sizes Pricing
T-2800s-20ea $ 2,379.00
T-2800s-30ea $ 2,704.00
T-2800s-40ea $ 3,569.00

Add a specific quantity to your cart    *  

Back to the webstore startpage      Back to the product overview      Your Shopping Cart      Terms of Service

assay and reagents for drug discovery in lipid signaling pathways